Helen Brooke Taussig and Edwards Albert Park: the early years (1927-1930)

William N Evans1

  • 1Children's Heart Center, Las Vegas, NV, USA. WNevans50@aol.com

Insights

The founding of the pediatric cardiology clinic at Johns Hopkins involved more than just Helen Taussig, highlighting institutional collaboration and the personal journeys of key figures like Edwards Park.

Area of Science:

  • Medical History
  • Pediatric Cardiology
  • Institutional Collaboration

Background:

  • The established narrative credits Helen Taussig with founding the pediatric cardiology clinic at Johns Hopkins in 1930.
  • This account often overlooks the intricate institutional collaborations and personal dynamics involved.

Discussion:

  • This article delves into the complex history of the clinic's establishment.
  • It examines the roles of Helen Taussig and Edwards Park, alongside institutional contributions.
  • Archival research at McGill University, Rockefeller Foundation, and Johns Hopkins provides new perspectives.

Key Insights:

  • The clinic's founding was a multifaceted process, not solely attributable to one individual.
  • Collaboration between institutions and the personal experiences of key figures were crucial.
  • A deeper understanding requires exploring diverse historical sources.

Outlook:

  • Further research into the early history of pediatric cardiology can refine our understanding of its development.
  • Recognizing collaborative efforts in historical accounts offers a more accurate portrayal of scientific progress.
  • Archival research remains vital for uncovering nuanced historical narratives.

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...